Alk-Abello AS (CHIX:ALKBC) FFO


CHIX:ALKBC Alk-Abello AS CHIX:ALKBC
92 GF Score
Price kr256.30
GF Value kr206.69
Valuation Modestly Overvalued
! 5 Warning Signs
View Full Analysis

What is Alk-Abello AS FFO?

FFO (Funds from operations) only applies to REITs.

CHIX:ALKBC
92GF Score
Alk-Abello AS CHIX:ALKBC
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Alk-Abello AS (CHIX:ALKBC) Overvalued in 2026?

Based on GuruFocus' analysis, Alk-Abello AS stock appears to be overvalued. The current stock price of kr256.30 is trading 24% above its estimated GF Value™ of kr206.69. GuruFocus considers Alk-Abello AS to be Modestly Overvalued.

Key valuation signals for CHIX:ALKBC:

  • FFO:
  • GF Value™: kr206.69 vs. price of kr256.30 (24% above fair value)
  • GF Score™: 92/100 with 5 warning signs

No single metric tells the full story. See the CHIX:ALKBC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Alk-Abello AS Business Description

Address Boge Alle 6-8, Horsholm, DNK, DK-2970
Alk-Abello AS is a biotechnology company that focuses on pharmaceutical prevention, diagnosis, and treatment of allergies. The company is focused on respiratory diseases, including allergic rhinitis and allergic asthma. Moreover, the firm specializes in venom immunotherapy for patients suffering from bee and wasp allergies. The company's treatments induce a protective immune response that provides sustained symptom relief. Its primary focus is on allergy patients whose disease is not well controlled, despite the use of symptom-relieving medication. The company operates in Europe, North America and International Markets. It derives maximum revenue from Europe.
92GF Score

Get the complete analysis for CHIX:ALKBC

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr256.30
Price
kr206.69
GF Value